Inicio › Enfermedad de Crohn › Kentucky
Ensayos clínicos de Enfermedad de Crohn en Kentucky
12 estudios sobre Enfermedad de Crohn buscan participantes en Kentucky.
Ciudades en Kentucky
Texto oficial del estudio (inglés)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-State Gastroenterology Associates, Crestview Hills
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06581328A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Louisville Hospital ( Site 5120), Louisville
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 29 sept 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Health Partners /ID# 284144, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07697456A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Tri-State Gastroenterology Assoc, Crestview Hills
- University of Louisville - MedCenter One, Louisville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University Of Louisville, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06233461Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- University of Kentucky Chandler Medical Center /ID# 265564, Lexington
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Health Partners, Louisville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Kentucky Hospital/UK Albert B. Chandler Hospital-Site Number: 8400058, Lexington
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184931Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of Louisville, Louisville
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Tri-State Gastroenterology Assoc, Crestview Hills
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577843Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Louisville, Louisville
ReclutandoFase 1/2
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 dic 2025 · NCT06721962De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.